Method, primer, probe and kit for screening and identifying BCR-ABL unusual fusion types

A very common and integrated technology, applied in biochemical equipment and methods, DNA/RNA fragments, recombinant DNA technology, etc., can solve the problems of monitoring, cost increase, low sensitivity, etc.

Active Publication Date: 2014-02-12
南昌艾迪康医学检验实验室有限公司
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This screening method judged by naked eyes has the following disadvantages: (1) There are cases of missed detection in the screening of uncommon types of BCR-ABL fusion gene
First of all, the premise of karyotype analysis is that the nucleated cells in the sample need to be cultured and have nuclear division phase; if the cell culture fails and there is no nuclear division phase, the analysis cannot be performed
Secondly, in the process of cell culture and proliferation, certain types of cells will overgrow, and if normal cells overgrow, the diseased cells will be "submerged" and cause the illusion of normal karyotype
In the case that the bone marrow cannot be extracted, the peripheral blood is extracted for karyotype analysis, and false negatives may also occur.
Furthermore, in some cases, the chromosomal translocation is extremely small, and the occult Ph chromosome appears, which cannot be found in the chromosome examination by naked eye analysis.
When the FISH method detects BCR-ABL fusion, although it does not need to culture cells, it can also detect the occult Ph chromosome, but the cost of the inspection is too high, and most patients will not choose this method for detection, so it is not true. The role of screening
(2) It is impossible to distinguish the specific type of BCR-ABL, so it is impossible to carry out targeted monitoring of minimal residual disease (Minimal Residua Disease, MRD)
(3) Low detection success rate and sensitivity
The disadvantages of multiplex PCR combined with agarose gel electrophoresis or sequencing are as follows: (1) there is non-specific amplification, and multiple PCR product bands will appear during electrophoresis, which is prone to false positives; (2) analysis by electrophoresis There is subjectivity in judging the results, especially in the monitoring of MRD, the critical results cannot be clearly analyzed and judged, and the cost will be increased through sequencing, and the time period will be greatly extended; (3) The sensitivity is lower than that of nested PCR and fluorescent PCR; (4) only qualitative detection; (5) time-consuming, if the PCR product is identified by electrophoresis, it will take 5-6 hours; if it is identified by sequencing, it will take 10-12 hours
Nested PCR combined with agarose gel electrophoresis or sequencing also has the following disadvantages: (1) The process is cumbersome and easy to pollute, and the judgment of critical results in electrophoresis identification is subjective; (2) There are many PCR reaction systems and high cost. Not suitable for high-throughput sample detection; (3) only qualitative detection; (4) time-consuming, if the PCR product is identified by electrophoresis, it takes 5-6 hours; if it is identified by sequencing, it takes 10-12 hours
Therefore, no matter whether multiplex PCR (mμltiplex PCR) or nested PCR (nested PCR) is used to amplify first, and then use agarose gel electrophoresis or sequencing to identify the uncommon type of BCR-ABL fusion gene, it cannot simultaneously meet the requirements. Advantages of high sensitivity and specificity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method, primer, probe and kit for screening and identifying BCR-ABL unusual fusion types
  • Method, primer, probe and kit for screening and identifying BCR-ABL unusual fusion types
  • Method, primer, probe and kit for screening and identifying BCR-ABL unusual fusion types

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0120] Extraction of blood RNA: add 1ml of 1× red blood cell lysate to a 1.5ml centrifuge tube, take 0.5ml of the blood sample to be tested, and mix by inversion. Centrifuge at 4000rpm for 3min, aspirate and discard the supernatant, add red blood cell lysate and wash once to obtain the desired cells; add 1 ml TotalRNA Isolation Reagent (Shanghai Pufei Biotechnology Co., Ltd.), blow and suck repeatedly until there is no obvious cell clump, add chloroform 200 μl, vortex for 30 s, and let stand on ice for 10 min. Next, centrifuge at 14,000 rpm for 10 min at 4°C. Transfer 450 μl of the supernatant to another centrifuge tube with a pipette, add an equal volume of pre-cooled isopropanol, invert and mix, and then let stand on ice for 10 min. Centrifuge at 14,000 rpm for 10 min at 4°C. Then wash and centrifuge once with 75% ethanol and absolute ethanol, respectively. Dry at room temperature for 5 min, add 50 μl DEPC-H2O to dissolve, and obtain RNA extract.

[0121] The formula for...

Embodiment 2

[0123] Reverse transcription: Take 4 μl of the RNA extract in Example 1 (concentration about 200 ng / μl), add 1 μl Primer mix (ReverTra AceqPCR RT Kit, purchased from Toyobo (Shanghai) Biotechnology Co., Ltd.) and 3 μl DEPC-H2O, and mix well. Pre-denaturation at 70°C for 5 min; after quenching on ice for 1 min, add 4 μl 5* RT buffer (ReverTra Ace qPCR RT Kit), 1 μl Enzyme Mix (ReverTra Ace qPCR RT Kit), and add 7 μl DEPC-H 2 0 to a total volume of 20 μl. The reaction was performed at 37°C for 60 minutes and then inactivated at 98°C for 5 minutes to obtain the cDNA of the blood sample to be tested.

Embodiment 3

[0125] Fluorescent PCR primary screening: Prepare primary screening reagents according to the materials and dosages shown in Table 1. The primary screening reagent contains three reaction tubes: one tube each for group a2, group a3 and ABL; ABL is the internal reference detection tube, which is used to judge whether the RNA extraction quality meets the requirements. 2 μl each of the cDNA obtained in Example 2 was added. The detection was performed according to the following procedure: pre-denaturation at 95°C for 30s; 95°C for 10s, 58°C for 35s, a total of 40 cycles; fluorescence was collected at 58°C. HUNDERBIRD Probe qPCR Mix was purchased from Toyobo (Shanghai) Biotechnology Co., Ltd.

[0126] Table 1

[0127]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method, primer, probe and kit for detecting six unusual fusion types of BCR-ABL fusion genes such as e6a2, e8a2, e19a2, e1a3, e13a3 and e14a3. The method comprises the following steps: performing primary screening on blood samples by adopting two tubes of fluorescent quantitative polymerase chain reaction (PCR), and quantitatively indentifying specific types of the blood samples belonging to the a2 or a3 group through primary screening judgment. Therefore, the screening cost is reduced, and the detection throughput is also improved. According to the detection method, primer, probe and kit, high sensitivity, high specificity and high detection throughput can be realized, and the method is a rapid and accurate type screening and identifying method.

Description

technical field [0001] The invention belongs to the fields of life science and biotechnology, and in particular relates to a method, primers, probes and kits for clinical screening of uncommon fusion types of BCR-ABL fusion genes. The six uncommon types of BCR-ABL fusion genes e6a2, e8a2, e19a2, e1a3, e13a3, and e14a3 were initially screened and identified. Background technique [0002] The BCR-ABL fusion gene is produced by the translocation of the long arm of chromosome 9 to the long arm of chromosome 22, resulting in the fusion of the ABL proto-oncogene and the BCR gene. Chromosome 22 after the t(9;22)(q34;q11) translocation is also called the Philadelphia chromosome (Ph chromosome). Ph chromosome and BCR-ABL fusion gene are the molecular basis of chronic myeloid leukemia (CML). In addition, the BCR-ABL fusion gene can also be found in acute lymphoblastic leukemia (ALL) and rarely in acute myeloid leukemia (AML). [0003] When chromosome 9 is translocated with chromoso...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12Q1/68C12N15/11
CPCC12Q1/686C12Q1/6886C12Q2537/143C12Q2563/107C12Q2600/16C12Q2531/113
Inventor 邹媛董越金海波陈红梅夏成青
Owner 南昌艾迪康医学检验实验室有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products